Analystreport

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating.

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com